The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
CytomX Therapeutics, Inc(NASDAQ:CTMX) 
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (AD...
CytomX Therapeutics Days Payable Outstanding ttm (DPO)
CytomX Therapeutics Days Receivable Outstanding ttm (DSO)
CytomX Therapeutics Days Inventory Outstanding ttm (DIO)
CytomX Therapeutics Op Cashflow Per Share ttm
CytomX Therapeutics Free Cashflow Per Share ttm
CytomX Therapeutics Cash Per Share ttm
CytomX Therapeutics P/S ratio ttm
CytomX Therapeutics (GAAP) P/E ratio ttm
CytomX Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.